IXICO plc (AIM: IXI)

Market Cap	11.12M
Revenue (ttm)	5.77M
Net Income (ttm)	-2.00M
Shares Out	92.67M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,400
Average Volume	18,332
Open	11.77
Previous Close	12.00
Day's Range	11.77 - 12.26
52-Week Range	6.35 - 13.00
Beta	0.68
RSI	67.91
Earnings Date	Dec 6, 2024

About IXICO

IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company’s technologies comprise Assessa, an online digital platform for clinics; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 81
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: IXI

Financial Performance

In 2024, IXICO's revenue was 5.77 million, a decrease of -13.49% compared to the previous year's 6.67 million. Losses were -2.00 million, 69.9% more than in 2023.